These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 39305342)

  • 1. Risk of bladder cancer in patients with type 2 diabetes mellitus: a retrospective population-based cohort study in Lithuania.
    Ladukas A; Patasius A; Kincius M; Drevinskaite M; Jonusas J; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Cancer Causes Control; 2024 Sep; ():. PubMed ID: 39305342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies.
    Ahmadinezhad M; Arshadi M; Hesari E; Sharafoddin M; Azizi H; Khodamoradi F
    Epidemiol Health; 2022; 44():e2022050. PubMed ID: 35638225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis.
    Liu CQ; Sun JX; Xu JZ; Qian XY; Hong SY; Xu MY; An Y; Xia QD; Hu J; Wang SG
    Front Pharmacol; 2022; 13():865988. PubMed ID: 35462910
    [No Abstract]   [Full Text] [Related]  

  • 4. The Sirenic Links between Diabetes, Obesity, and Bladder Cancer.
    Gill E; Sandhu G; Ward DG; Perks CM; Bryan RT
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Resistance and Cancer: In Search for a Causal Link.
    Chiefari E; Mirabelli M; La Vignera S; Tanyolaç S; Foti DP; Aversa A; Brunetti A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 Diabetes Mellitus and Cancer: Epidemiology, Physiopathology and Prevention.
    Rey-Reñones C; Baena-Díez JM; Aguilar-Palacio I; Miquel C; Grau M
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study.
    Rastad H; Parsaeian M; Shirzad N; Mansournia MA; Yazdani K
    J Diabetes Metab Disord; 2019 Jun; 18(1):65-72. PubMed ID: 31275876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.
    Cumberbatch MGK; Jubber I; Black PC; Esperto F; Figueroa JD; Kamat AM; Kiemeney L; Lotan Y; Pang K; Silverman DT; Znaor A; Catto JWF
    Eur Urol; 2018 Dec; 74(6):784-795. PubMed ID: 30268659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
    Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and cancer: Pathophysiological fundamentals of a 'dangerous affair'.
    Cignarelli A; Genchi VA; Caruso I; Natalicchio A; Perrini S; Laviola L; Giorgino F
    Diabetes Res Clin Pract; 2018 Sep; 143():378-388. PubMed ID: 29679627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.
    Tang H; Shi W; Fu S; Wang T; Zhai S; Song Y; Han J
    Cancer Med; 2018 Apr; 7(4):1070-1080. PubMed ID: 29476615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.
    Xu Y; Huo R; Chen X; Yu X
    Medicine (Baltimore); 2017 Nov; 96(46):e8588. PubMed ID: 29145273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.
    Chen HF; Chen SW; Chang YH; Li CY
    Medicine (Baltimore); 2015 Sep; 94(38):e1494. PubMed ID: 26402804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.
    Cumberbatch MG; Rota M; Catto JW; La Vecchia C
    Eur Urol; 2016 Sep; 70(3):458-66. PubMed ID: 26149669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.
    Mamtani R; Pfanzelter N; Haynes K; Finkelman BS; Wang X; Keefe SM; Haas NB; Vaughn DJ; Lewis JD
    Diabetes Care; 2014 Jul; 37(7):1910-7. PubMed ID: 24496803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.
    Fang H; Yao B; Yan Y; Xu H; Liu Y; Tang H; Zhou J; Cao L; Wang W; Zhang J; Zhao L; Chen X; Zhang F; Zhao Y
    Diabetes Technol Ther; 2013 Nov; 15(11):914-22. PubMed ID: 24180357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.
    Zhu Z; Wang X; Shen Z; Lu Y; Zhong S; Xu C
    BMC Cancer; 2013 Jun; 13():310. PubMed ID: 23803148
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.